Global and United States DNA Repair Drugs Market Report & Forecast 2022-2028

Global and United States DNA Repair Drugs Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 DNA Repair Drugs Product Introduction
1.2 Global DNA Repair Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global DNA Repair Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global DNA Repair Drugs Sales in Volume for the Year 2017-2028
1.3 United States DNA Repair Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States DNA Repair Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States DNA Repair Drugs Sales in Volume for the Year 2017-2028
1.4 DNA Repair Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States DNA Repair Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of DNA Repair Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 DNA Repair Drugs Market Dynamics
1.5.1 DNA Repair Drugs Industry Trends
1.5.2 DNA Repair Drugs Market Drivers
1.5.3 DNA Repair Drugs Market Challenges
1.5.4 DNA Repair Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 DNA Repair Drugs Market Segment by Type
2.1.1 PARP Inhibitors
2.1.2 Other
2.2 Global DNA Repair Drugs Market Size by Type
2.2.1 Global DNA Repair Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global DNA Repair Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global DNA Repair Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States DNA Repair Drugs Market Size by Type
2.3.1 United States DNA Repair Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States DNA Repair Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States DNA Repair Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 DNA Repair Drugs Market Segment by Application
3.1.1 Oncological
3.1.2 Stroke
3.2 Global DNA Repair Drugs Market Size by Application
3.2.1 Global DNA Repair Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global DNA Repair Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global DNA Repair Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States DNA Repair Drugs Market Size by Application
3.3.1 United States DNA Repair Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States DNA Repair Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States DNA Repair Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global DNA Repair Drugs Competitor Landscape by Company
4.1 Global DNA Repair Drugs Market Size by Company
4.1.1 Top Global DNA Repair Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global DNA Repair Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global DNA Repair Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global DNA Repair Drugs Price by Manufacturer (2017-2022)
4.2 Global DNA Repair Drugs Concentration Ratio (CR)
4.2.1 DNA Repair Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of DNA Repair Drugs in 2021
4.2.3 Global DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global DNA Repair Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global DNA Repair Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers DNA Repair Drugs Product Type
4.3.3 Date of International Manufacturers Enter into DNA Repair Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States DNA Repair Drugs Market Size by Company
4.5.1 Top DNA Repair Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States DNA Repair Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States DNA Repair Drugs Sales by Players (2020, 2021 & 2022)
5 Global DNA Repair Drugs Market Size by Region
5.1 Global DNA Repair Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global DNA Repair Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global DNA Repair Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global DNA Repair Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global DNA Repair Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global DNA Repair Drugs Sales in Value by Region: 2017-2022
5.3.2 Global DNA Repair Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America DNA Repair Drugs Market Size YoY Growth 2017-2028
6.1.2 North America DNA Repair Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific DNA Repair Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific DNA Repair Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe DNA Repair Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe DNA Repair Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America DNA Repair Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America DNA Repair Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa DNA Repair Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa DNA Repair Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 4SC AG
7.1.1 4SC AG Corporation Information
7.1.2 4SC AG Description and Business Overview
7.1.3 4SC AG DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 4SC AG DNA Repair Drugs Products Offered
7.1.5 4SC AG Recent Development
7.2 ARCAGY/ GINECO GROUP
7.2.1 ARCAGY/ GINECO GROUP Corporation Information
7.2.2 ARCAGY/ GINECO GROUP Description and Business Overview
7.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Products Offered
7.2.5 ARCAGY/ GINECO GROUP Recent Development
7.3 Bristol Myers Squibb
7.3.1 Bristol Myers Squibb Corporation Information
7.3.2 Bristol Myers Squibb Description and Business Overview
7.3.3 Bristol Myers Squibb DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Bristol Myers Squibb DNA Repair Drugs Products Offered
7.3.5 Bristol Myers Squibb Recent Development
7.4 British Columbia Cancer Agency
7.4.1 British Columbia Cancer Agency Corporation Information
7.4.2 British Columbia Cancer Agency Description and Business Overview
7.4.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 British Columbia Cancer Agency DNA Repair Drugs Products Offered
7.4.5 British Columbia Cancer Agency Recent Development
7.5 Cambridge University Hospitals NHS Foundation Trust
7.5.1 Cambridge University Hospitals NHS Foundation Trust Corporation Information
7.5.2 Cambridge University Hospitals NHS Foundation Trust Description and Business Overview
7.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Products Offered
7.5.5 Cambridge University Hospitals NHS Foundation Trust Recent Development
7.6 Genentech
7.6.1 Genentech Corporation Information
7.6.2 Genentech Description and Business Overview
7.6.3 Genentech DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Genentech DNA Repair Drugs Products Offered
7.6.5 Genentech Recent Development
7.7 Georgetown University
7.7.1 Georgetown University Corporation Information
7.7.2 Georgetown University Description and Business Overview
7.7.3 Georgetown University DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Georgetown University DNA Repair Drugs Products Offered
7.7.5 Georgetown University Recent Development
7.8 German Breast Group
7.8.1 German Breast Group Corporation Information
7.8.2 German Breast Group Description and Business Overview
7.8.3 German Breast Group DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 German Breast Group DNA Repair Drugs Products Offered
7.8.5 German Breast Group Recent Development
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Corporation Information
7.9.2 GlaxoSmithKline Description and Business Overview
7.9.3 GlaxoSmithKline DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 GlaxoSmithKline DNA Repair Drugs Products Offered
7.9.5 GlaxoSmithKline Recent Development
7.10 Jiangsu Hengrui Medicine
7.10.1 Jiangsu Hengrui Medicine Corporation Information
7.10.2 Jiangsu Hengrui Medicine Description and Business Overview
7.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Products Offered
7.10.5 Jiangsu Hengrui Medicine Recent Development
7.11 Johnson & Johnson
7.11.1 Johnson & Johnson Corporation Information
7.11.2 Johnson & Johnson Description and Business Overview
7.11.3 Johnson & Johnson DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Johnson & Johnson DNA Repair Drugs Products Offered
7.11.5 Johnson & Johnson Recent Development
7.12 Jonsson Comprehensive Cancer Center
7.12.1 Jonsson Comprehensive Cancer Center Corporation Information
7.12.2 Jonsson Comprehensive Cancer Center Description and Business Overview
7.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Jonsson Comprehensive Cancer Center Products Offered
7.12.5 Jonsson Comprehensive Cancer Center Recent Development
7.13 Karyopharm Therapeutics
7.13.1 Karyopharm Therapeutics Corporation Information
7.13.2 Karyopharm Therapeutics Description and Business Overview
7.13.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Karyopharm Therapeutics Products Offered
7.13.5 Karyopharm Therapeutics Recent Development
7.14 KuDOS Pharmaceuticals
7.14.1 KuDOS Pharmaceuticals Corporation Information
7.14.2 KuDOS Pharmaceuticals Description and Business Overview
7.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 KuDOS Pharmaceuticals Products Offered
7.14.5 KuDOS Pharmaceuticals Recent Development
7.15 National Health Service
7.15.1 National Health Service Corporation Information
7.15.2 National Health Service Description and Business Overview
7.15.3 National Health Service DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 National Health Service Products Offered
7.15.5 National Health Service Recent Development
7.16 National Institutes of Health
7.16.1 National Institutes of Health Corporation Information
7.16.2 National Institutes of Health Description and Business Overview
7.16.3 National Institutes of Health DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 National Institutes of Health Products Offered
7.16.5 National Institutes of Health Recent Development
7.17 Tesaro
7.17.1 Tesaro Corporation Information
7.17.2 Tesaro Description and Business Overview
7.17.3 Tesaro DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Tesaro Products Offered
7.17.5 Tesaro Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 DNA Repair Drugs Industry Chain Analysis
8.2 DNA Repair Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 DNA Repair Drugs Distributors
8.3 DNA Repair Drugs Production Mode & Process
8.4 DNA Repair Drugs Sales and Marketing
8.4.1 DNA Repair Drugs Sales Channels
8.4.2 DNA Repair Drugs Distributors
8.5 DNA Repair Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. DNA Repair Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. DNA Repair Drugs Market Trends
Table 3. DNA Repair Drugs Market Drivers
Table 4. DNA Repair Drugs Market Challenges
Table 5. DNA Repair Drugs Market Restraints
Table 6. Global DNA Repair Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States DNA Repair Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global DNA Repair Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States DNA Repair Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top DNA Repair Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global DNA Repair Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global DNA Repair Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global DNA Repair Drugs Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global DNA Repair Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global DNA Repair Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global DNA Repair Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global DNA Repair Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Repair Drugs as of 2021)
Table 18. Top Players of DNA Repair Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers DNA Repair Drugs Product Type
Table 20. Date of International Manufacturers Enter into DNA Repair Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top DNA Repair Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States DNA Repair Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States DNA Repair Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States DNA Repair Drugs Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States DNA Repair Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global DNA Repair Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global DNA Repair Drugs Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global DNA Repair Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global DNA Repair Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global DNA Repair Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America DNA Repair Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America DNA Repair Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific DNA Repair Drugs Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific DNA Repair Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe DNA Repair Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe DNA Repair Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America DNA Repair Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa DNA Repair Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa DNA Repair Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa DNA Repair Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. 4SC AG Corporation Information
Table 43. 4SC AG Description and Business Overview
Table 44. 4SC AG DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. 4SC AG DNA Repair Drugs Product
Table 46. 4SC AG Recent Development
Table 47. ARCAGY/ GINECO GROUP Corporation Information
Table 48. ARCAGY/ GINECO GROUP Description and Business Overview
Table 49. ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. ARCAGY/ GINECO GROUP Product
Table 51. ARCAGY/ GINECO GROUP Recent Development
Table 52. Bristol Myers Squibb Corporation Information
Table 53. Bristol Myers Squibb Description and Business Overview
Table 54. Bristol Myers Squibb DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Bristol Myers Squibb Product
Table 56. Bristol Myers Squibb Recent Development
Table 57. British Columbia Cancer Agency Corporation Information
Table 58. British Columbia Cancer Agency Description and Business Overview
Table 59. British Columbia Cancer Agency DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. British Columbia Cancer Agency Product
Table 61. British Columbia Cancer Agency Recent Development
Table 62. Cambridge University Hospitals NHS Foundation Trust Corporation Information
Table 63. Cambridge University Hospitals NHS Foundation Trust Description and Business Overview
Table 64. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Cambridge University Hospitals NHS Foundation Trust Product
Table 66. Cambridge University Hospitals NHS Foundation Trust Recent Development
Table 67. Genentech Corporation Information
Table 68. Genentech Description and Business Overview
Table 69. Genentech DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Genentech Product
Table 71. Genentech Recent Development
Table 72. Georgetown University Corporation Information
Table 73. Georgetown University Description and Business Overview
Table 74. Georgetown University DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Georgetown University Product
Table 76. Georgetown University Recent Development
Table 77. German Breast Group Corporation Information
Table 78. German Breast Group Description and Business Overview
Table 79. German Breast Group DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. German Breast Group Product
Table 81. German Breast Group Recent Development
Table 82. GlaxoSmithKline Corporation Information
Table 83. GlaxoSmithKline Description and Business Overview
Table 84. GlaxoSmithKline DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. GlaxoSmithKline Product
Table 86. GlaxoSmithKline Recent Development
Table 87. Jiangsu Hengrui Medicine Corporation Information
Table 88. Jiangsu Hengrui Medicine Description and Business Overview
Table 89. Jiangsu Hengrui Medicine DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Jiangsu Hengrui Medicine Product
Table 91. Jiangsu Hengrui Medicine Recent Development
Table 92. Johnson & Johnson Corporation Information
Table 93. Johnson & Johnson Description and Business Overview
Table 94. Johnson & Johnson DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. Johnson & Johnson Product
Table 96. Johnson & Johnson Recent Development
Table 97. Jonsson Comprehensive Cancer Center Corporation Information
Table 98. Jonsson Comprehensive Cancer Center Description and Business Overview
Table 99. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 100. Jonsson Comprehensive Cancer Center Product
Table 101. Jonsson Comprehensive Cancer Center Recent Development
Table 102. Karyopharm Therapeutics Corporation Information
Table 103. Karyopharm Therapeutics Description and Business Overview
Table 104. Karyopharm Therapeutics DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 105. Karyopharm Therapeutics Product
Table 106. Karyopharm Therapeutics Recent Development
Table 107. KuDOS Pharmaceuticals Corporation Information
Table 108. KuDOS Pharmaceuticals Description and Business Overview
Table 109. KuDOS Pharmaceuticals DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. KuDOS Pharmaceuticals Product
Table 111. KuDOS Pharmaceuticals Recent Development
Table 112. National Health Service Corporation Information
Table 113. National Health Service Description and Business Overview
Table 114. National Health Service DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. National Health Service Product
Table 116. National Health Service Recent Development
Table 117. National Institutes of Health Corporation Information
Table 118. National Institutes of Health Description and Business Overview
Table 119. National Institutes of Health DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. National Institutes of Health Product
Table 121. National Institutes of Health Recent Development
Table 122. Tesaro Corporation Information
Table 123. Tesaro Description and Business Overview
Table 124. Tesaro DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Tesaro Product
Table 126. Tesaro Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. DNA Repair Drugs Customers List
Table 130. DNA Repair Drugs Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. DNA Repair Drugs Product Picture
Figure 2. Global DNA Repair Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global DNA Repair Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global DNA Repair Drugs Sales 2017-2028 (K Units)
Figure 5. United States DNA Repair Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States DNA Repair Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States DNA Repair Drugs Sales 2017-2028 (K Units)
Figure 8. United States DNA Repair Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States DNA Repair Drugs Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. DNA Repair Drugs Report Years Considered
Figure 11. Product Picture of PARP Inhibitors
Figure 12. Product Picture of Other
Figure 13. Global DNA Repair Drugs Market Share by Type in 2022 & 2028
Figure 14. Global DNA Repair Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global DNA Repair Drugs Sales Market Share in Value by Type (2017-2028)
Figure 16. Global DNA Repair Drugs Sales by Type (2017-2028) & (K Units)
Figure 17. Global DNA Repair Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global DNA Repair Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 19. United States DNA Repair Drugs Market Share by Type in 2022 & 2028
Figure 20. United States DNA Repair Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States DNA Repair Drugs Sales Market Share in Value by Type (2017-2028)
Figure 22. United States DNA Repair Drugs Sales by Type (2017-2028) & (K Units)
Figure 23. United States DNA Repair Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States DNA Repair Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 25. Product Picture of Oncological
Figure 26. Product Picture of Stroke
Figure 27. Global DNA Repair Drugs Market Share by Application in 2022 & 2028
Figure 28. Global DNA Repair Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 29. Global DNA Repair Drugs Sales Market Share in Value by Application (2017-2028)
Figure 30. Global DNA Repair Drugs Sales by Application (2017-2028) & (K Units)
Figure 31. Global DNA Repair Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 32. Global DNA Repair Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 33. United States DNA Repair Drugs Market Share by Application in 2022 & 2028
Figure 34. United States DNA Repair Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 35. United States DNA Repair Drugs Sales Market Share in Value by Application (2017-2028)
Figure 36. United States DNA Repair Drugs Sales by Application (2017-2028) & (K Units)
Figure 37. United States DNA Repair Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 38. United States DNA Repair Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America DNA Repair Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 40. North America DNA Repair Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 41. U.S. DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 42. Canada DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Europe DNA Repair Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 44. Europe DNA Repair Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. Germany DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. France DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. U.K. DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Italy DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Russia DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Asia-Pacific DNA Repair Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 51. Asia-Pacific DNA Repair Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 52. China DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Japan DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. South Korea DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. India DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Australia DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Taiwan DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Indonesia DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Thailand DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Malaysia DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Philippines DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Latin America DNA Repair Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 63. Latin America DNA Repair Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 64. Mexico DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Brazil DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Argentina DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Middle East & Africa DNA Repair Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 68. Middle East & Africa DNA Repair Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Turkey DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Saudi Arabia DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. U.A.E DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. DNA Repair Drugs Value Chain
Figure 73. DNA Repair Drugs Production Process
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs